BofA Securities analyst Geoff Meacham upgraded Biogen (NASDAQ: BIIB) from Underperform to Neutral.

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $247.01 yesterday.